<DOC>
	<DOCNO>NCT01734356</DOCNO>
	<brief_summary>The recent development research iPS ( induced pluripotent stem ) cell lead establishment mature cell line cardiomyocytes valvular interstitial cell genetic cellular characteristic donor . These cell represent biological material readily available identify pathophysiological mechanism involve disease BrS ERS patient , lead identification genetic marker .</brief_summary>
	<brief_title>Molecular Mechanism Identification Inherited Arrhythmias Valvulopathies From Induced Pluripotent Stem Cells</brief_title>
	<detailed_description />
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>Inclusion criterion : Patient family history inherit arrhythmia valvulopathy Age : 2260 yo . patient confine bed Male female Written consent Patient affiliate French social security Exclusion criterion : Pregnant woman Patient 22 yo adult guardianship Indication local anesthesia Anticoagulant treatment Absence positivity HIV , HBV , HCV serology</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>iPS</keyword>
	<keyword>fibroblast</keyword>
	<keyword>arrhythmia</keyword>
	<keyword>valvulopathies</keyword>
	<keyword>electrophysiology</keyword>
	<keyword>genetics</keyword>
</DOC>